Fundamental Research Analysts Give Zepp Health (NYSE:ZEPP) a $53.01 Price Target

Fundamental Research set a $53.01 target price on Zepp Health (NYSE:ZEPPFree Report) in a report published on Tuesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.

Separately, Wall Street Zen cut shares of Zepp Health from a “hold” rating to a “sell” rating in a report on Sunday, July 26th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $53.01.

Check Out Our Latest Research Report on Zepp Health

Zepp Health Stock Performance

Shares of Zepp Health stock opened at $5.39 on Tuesday. The stock has a market cap of $79.15 million, a price-to-earnings ratio of -2.14 and a beta of 1.86. The firm’s 50-day moving average is $4.99 and its 200 day moving average is $11.93. Zepp Health has a 1 year low of $3.85 and a 1 year high of $61.85. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.88 and a quick ratio of 0.67.

Insider Activity at Zepp Health

In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of Zepp Health stock in a transaction on Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the completion of the sale, the chief financial officer owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. This trade represents a 7.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 36.00% of the company’s stock.

Institutional Investors Weigh In On Zepp Health

Institutional investors have recently modified their holdings of the business. Public Employees Retirement System of Ohio raised its position in Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock worth $41,000 after buying an additional 576 shares during the last quarter. Osaic Holdings Inc. boosted its holdings in shares of Zepp Health by 239.5% during the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after acquiring an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP purchased a new stake in shares of Zepp Health during the 4th quarter valued at about $241,000. Capstone Capital Management Ltd bought a new stake in shares of Zepp Health in the fourth quarter worth approximately $298,000. Finally, Mangrove Partners IM LLC bought a new stake in shares of Zepp Health in the fourth quarter worth approximately $387,000. 52.61% of the stock is owned by hedge funds and other institutional investors.

About Zepp Health

(Get Free Report)

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.

Further Reading

Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.